Skip to content

Clinical trials

Cardiomyopathy, Dilated trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20051
20061
20077
20083
20093
20101
20113
20121
20133
20143
20151
20162
20186
20192
20204
20212
20221
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated12
Recruiting9
Active, not recruiting5
Unknown status3
Withdrawn2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ancora Heart, Inc.3
Johns Hopkins University3
Pfizer3
University of Colorado, Denver3
University of Pennsylvania3
Bristol-Myers Squibb2
Emory University2
National Heart, Lung, and Blood Institute (NHLBI)2
Vericel Corporation2
Wayne State University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated59
Heart Failure26
Cardiomyopathy, Hypertrophic11
Cardiomyopathies8
Heart Diseases7
Cardiovascular Diseases5
Cardiomyopathy, Restrictive4
Death, Sudden, Cardiac3
Arrhythmias, Cardiac2
Arrhythmogenic Right Ventricular Dysplasia2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.